|
Otálora BB, Madrid JA, Alvarez N, Vicente V, Rol MA. Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma-bearing C57BL6 mice. J Pineal Res. 2008 Apr;44(3):307-15. doi: 10.1111/j.1600-079X.2007.00531.x. PubMed PMID: 18339126.
AÑO: 2008; IF: 5.056
|
18339126
|
Moreno MJ, Lozano ML, Roldán V, Bellosillo B, García-Barberá N, Rivera J, Navarro-Núñez L, Besses C, Vicente V, Martínez C. JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia. Ann Hematol. 2008 Sep;87(9):763-5. doi: 10.1007/s00277-008-0474-z. Epub 2008 Mar 26. PubMed PMID: 18365193.
AÑO: 2008; IF: 2.454
|
|
Navarro-Núñez L, Roldán V, Lozano ML, Rivera J, Marin F, Vicente V, Martínez C. TUBB1 Q43P polymorphism does not protect against acute coronary syndrome and premature myocardial infarction. Thromb Haemost. 2008 Dec;100(6):1211-3. PubMed PMID: 19132255.
AÑO: 2008; IF: 3.803
|
|
Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Haematologica. 2008 May;93(5):729-34. doi: 10.3324/haematol.12271. Epub 2008 Apr 2. PubMed PMID: 18387978.
AÑO: 2008; IF: 5.978
|
|
Solá E, Vayá A, España F, Castelló R, Ramón LA, Hernández-Mijares A, Vicente V, Estellés A. Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism. Thromb Res. 2008;122(3):320-7. Epub 2007 Nov 26. PubMed PMID: 18037477.
AÑO: 2008; IF: 2.449
|